From serving at Ground Zero after September 11th to advancing patient-centered oncology care at Daiichi Sankyo, John Ruggiero shares how resilience, compassion, and purpose shaped his journey into the pharmaceutical industry. As Executive Director, U.S. Medical Affairs, HEOR, he reflects on cancer research, patient empowerment, and the culture that keeps him inspired.
I had no idea what to expect when I was deployed to Ground Zero. In moments like that, you do not hesitate, you jump into action. You do everything you can to help reconnect families.
Working at Daiichi Sankyo, cancer was part of my everyday life. But this was different. This was my dad, and it was a diagnosis I knew would not end with the ringing of a bell…
In certain cancers, HER2 becomes overexpressed or uncontrolled, driving tumors to develop quickly. As our understanding of HER2 and its role deepens, its relevance across endometrial, ovarian and other gynecologic tumors has become…
Daiichi Sankyo CARE Teams go above and beyond educating healthcare providers about our medicines and providing patient support. Discover how we CARE...
The role of Medical Affairs is to bridge the gap between scientific research and real-world medical practice. After 17 years, I’ve seen firsthand ...
While our lungs support our very existence, we often don’t recognize that something isn’t quite right with our lung health. Get answers to questions about lung cancer and listen to empowered patients...